Enzene Biosciences

Pune, India Founded: 2006 • Age: 20 yrs
Company specializing in development of Biosimilars

About Enzene Biosciences

Enzene Biosciences is a Healthcare company based in Pune (India) founded in 2006. Company specializing in development of Biosimilars. Enzene Biosciences has raised $50 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 1,023 employees. Its website enzene.com draws about 22 thousand monthly visits. Its Indian entity Enzene Biosciences Limited reported revenue of ₹468 Cr. Enzene Biosciences offers products and services including EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.

Company details

Enzene Biosciences was founded in 2006 in Pune, India, as a subsidiary of Alkem Laboratories Limited. Operations are centered on biosimilars in the biotechnology sector, with platforms established in molecular biology, protein expression, and fermentation for microbial, insect, and mammalian cells. Expertise includes upstream and downstream process development, bio-analytics for peptides and proteins, cell-based bioassays, and peptide synthesis via solution and solid-state methods.

Key Metrics
  • Annual Revenue
    ₹468 Cr

    FY 2026 · +33% YoY

  • Net Loss
    -₹150 Cr

    FY 2026 · -31% margin

  • EBITDA
    -₹43.30 Cr

    FY 2026 · -9% margin

  • Total Equity Funding
    $50M (USD)

    in 1 rounds

  • Latest Funding Round
    $50M (USD), Series C

    Jan 2023

  • Investors
  • Employee Count
    1,023

Products & Services of Enzene Biosciences

Enzene Biosciences offers a comprehensive portfolio of products and services, including EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services.

EnzeneX Platform
Manufacturing Platform

Continuous bioprocess for efficient biologics production and cost reduction

Drug Discovery Services
R&D Services

Solutions for target identification and antibody engineering processes

Drug Development Services
Development Services

Support for cell line engineering and formulation development

Drug Manufacturing Services
Production Services

Tech transfer and scale-up for biologics manufacturing

Apps and channels of Enzene Biosciences

its YouTube channel Enzene has 188 subscribers and 23 videos.

Enzene
YouTube 188 subscribers 23 videos Science & Technology
Open channel

Videos from Enzene Biosciences

The most watched videos on Enzene Biosciences's YouTube channel, Enzene (188 subscribers). Click a video to play it here.

Biologics Manufacturing Services: Pioneering the Future of Biologics Production
678 views
Innovating Biologics To Make Healthcare More Accessible: Enzene Corporate Video
631 views
Fill-Finish Services: cGMP-Compliant, Sterile & Scalable Solutions for Biologics Manufacturing
422 views
Breaking barriers in biologics manufacturing: EnzeneX™ to EnzeneX™ 2.0 #biomanufacturing #innovation
379 views

More on Enzene.

Funding Insights of Enzene Biosciences

Enzene Biosciences has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Series C round of $50 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $50M
  • Total Rounds 1
  • Last Round Series C — $50M
  • First Round $50M

    (Jan 2023)

  • Investors Count 2

All 1 funding rounds of Enzene Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2023$50MSeries C––
Valuation history

2 investors in total: 2 institutional.

Investors in Enzene Biosciences

Enzene Biosciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital investment and global platform support for startups.
2008eightroads.comLondon, United Kingdom
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
fprimecapital.com
Premium access

Investor details for Enzene Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Enzene Biosciences Limited (Enzene Biosciences)

Enzene Biosciences Limited is the primary company behind Enzene Biosciences. The boards of the 2 registered companies of Enzene Biosciences currently have 17 directors; the longest-serving is Basudeo Narayan Singh, appointed in 1973. 36 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Basudeo Narayan Singh
DIN 00760310
Whole-time director08 Aug 197353 yrs 3 moAlkem Laboratories Limited
Mritunjay Kumar Singh
DIN 00881412
Whole-time director11 Feb 200818 yrs 9 moAlkem Laboratories Limited, Enzene Biosciences Limited
Sandeep Singh
DIN 01277984
Managing Director09 Aug 201313 yrs 3 moAlkem Laboratories Limited, Enzene Biosciences Limited
Himanshu Shashikant Gadgil
DIN 07548149
Whole-time director09 Feb 20179 yrs 9 moEnzene Biosciences Limited
Sarvesh Singh
DIN 01278229
Whole-time director11 Nov 20197 yrsAlkem Laboratories Limited
Narendra Kumar Aneja
DIN 00124302
Director16 Mar 20206 yrs 8 moAlkem Laboratories Limited, Enzene Biosciences Limited
Madhurima Singh
DIN 09137323
Whole-time director20 Dec 20214 yrs 11 moAlkem Laboratories Limited
Sangeeta Kapil Jit Singh
DIN 06920906
Director02 Aug 20224 yrs 3 moEnzene Biosciences Limited
Sujjain Suresh Talwar
DIN 01756539
Director05 Aug 20224 yrs 3 moAlkem Laboratories Limited
Srinivas Balmiki Prasad Singh
DIN 06744441
Whole-time director14 Sep 20224 yrs 2 moAlkem Laboratories Limited, Enzene Biosciences Limited
Prem Pavoor
DIN 05268309
Director30 Jan 20233 yrs 9 moEnzene Biosciences Limited
Rajeev Kher
DIN 01192524
Director09 Aug 20242 yrs 3 moAlkem Laboratories Limited
Aniruddha Singh
DIN 09137325
Director07 Mar 20251 yr 8 moEnzene Biosciences Limited
Laxmana Ranjal Shenoy
DIN 00074761
Director13 Jul 20251 yr 4 moAlkem Laboratories Limited
Neela Bhattacherjee
DIN 01912483
Director13 Jul 20251 yr 4 moAlkem Laboratories Limited
Diwakar Gupta
DIN 01274552
Director13 Jul 20251 yr 4 moAlkem Laboratories Limited
Ketan Mahendra Patel
DIN 07229648
Director22 May 20266 moEnzene Biosciences Limited

People of Enzene Biosciences

82 people are tracked at Enzene Biosciences (30 in leadership, 6 in board & advisors, 46 in team); the tracked headcount is 1,023.

NameRoleGroup
Rebekah Clark
Director Of Sales OperationsLeadership
Arindam Chakraborty
General ManagerLeadership
Royston Pinto
Director Of Marketing And Public RelationsLeadership
Ramesh Kuril
Sr. General Manager & Head Regulatory AffairsLeadership
Neel Ambani
Chief Financial OfficerLeadership
CEOLeadership
Wouter Huizinga
Executive Director Sales & Business DevelopmentLeadership
Sushil Momaya
General Manager, Sales And Business DevelopmentLeadership
Pankaj Gour
Sr. General Manager & Head Of MSATLeadership
Norm Stoffregen
Senior Vice President & Site HeadLeadership
Russell Miller
Vice President Global Sales & MarketingLeadership
Anant Suri
Director Business Development- ProductsLeadership
Lourdes Gonzalez-Novo
Chief Commercial Officer (cco)Leadership
Shilpa Gadgil
Vice PresidentLeadership
Dharmesh Chaudhari
Senior Manager QA And Site HeadLeadership
Kamalamani Palle
Head - ITLeadership
Harsh Vahia
Assistant General Manager - Business FinanceLeadership
Yukhti Yachha
Senior Director, Global Business Development- BiologicsLeadership
Veena Pai Raiker
Senior General Manager And Head Of Project ManagementLeadership
Jin Kim
Executive Director Of Business DevelopmentLeadership

62 more people are available in the full profile.

Premium access

Complete people profiles for Enzene Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Enzene Biosciences

Figures of Enzene Biosciences Limited, the primary company behind Enzene Biosciences, for FY 2026. Revenue was ₹468 Cr (+33% year on year). Net loss was -₹150 Cr (-31% margin). EBITDA was -₹43.30 Cr (-9% margin). Revenue has grown at a compounded annual rate of +50% over three years and 0% over five years.

  • ₹468 CrRevenue · FY 2026 · +33% YoY
  • -₹150 CrNet loss · -31% margin
  • -₹43.30 CrEBITDA · -9% margin
  • ₹58.45 CrPaid-up capital
  • 665Employees (provident fund records)
  • +50%Revenue CAGR, 3 years
  • 0%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Enzene Biosciences Limited are on its company page.

Premium access

Detailed financial statements for Enzene Biosciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Enzene Biosciences

2 dated milestones of Enzene Biosciences across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Enzene Biosciences is founded.
  2. Funding First funding round of $50.0M.

Web traffic of Enzene Biosciences

The website of Enzene Biosciences (enzene.com) receives about 22.2K visits a month.

  • Monthly visits
    22.2K

    ▼ 22% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Enzene Biosciences (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Enzene Biosciences

Premium access

Complete news archive for Enzene Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Enzene Biosciences

Enzene Biosciences was founded in 2006 and raised its 1st funding round 17 years after it was founded.

Enzene Biosciences is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Enzene Biosciences is a funded company, having raised a total of $50M across 1 funding round to date. The company's 1st funding round was a Series C of $50M, raised on Jan 2023.

Enzene Biosciences has 1,023 employees.

The primary company behind Enzene Biosciences, Enzene Biosciences Limited, reported revenue of ₹468 Cr for FY 2026, up 33% year on year.

Enzene Biosciences was founded in 2006 in Pune, India, as a subsidiary of Alkem Laboratories Limited. Operations are centered on biosimilars in the biotechnology sector, with platforms established in molecular biology, protein expression, and fermentation for microbial, insect, and mammalian cells. Expertise includes upstream and downstream process development, bio-analytics for peptides and proteins, cell-based bioassays, and peptide synthesis via solution and solid-state methods.

Enzene Biosciences offers EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services.

Enzene Biosciences has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.

Enzene Biosciences is associated with 2 legal entities: Enzene Biosciences Limited, Alkem Laboratories Limited.

The legal entities of Enzene Biosciences currently have 20 directors, including Manish Narang, Sujjain Suresh Talwar, Srinivas Balmiki Prasad Singh and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available